BioCentury | Jan 23, 2021
Emerging Company Profile

ONK’s CAR NK cells hit the TRAIL

...2015, has applied its dual targeting allogeneic NK cell platform to four preclinical programs.Last year, ONK Therapeutics Ltd....
...1 SIGLEC7- Sialic acid binding Ig like lectin 7TRAIL - Tumor necrosis factor -related apoptosis-inducing ligand Karen Tkach Tuzman ONK Therapeutics Ltd. Glycotope...
BioCentury | Jan 16, 2021
Management Tracks

FDA’s Schiller joins Aetion; plus Novavax, NHC, NextCure, Ziopharm, ONK

...biotechs, including GenScript Biotech Corp. (HKEX:1548), Legend Biotech Corp. (NASDAQ:LEGN) and Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688).ONK Therapeutics Ltd. appointed...
...succeeds founder Anthony Killarney, who remains on the board of the Irish cell therapy company. BC Staff Novavax Aetion FDA Ziopharm ONK Therapeutics Ltd. NextCure...
BioCentury | Oct 20, 2020
Deals

Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta

...the treatment to patients for decades at no charge.ONK raises $8M, appoints Chris Nowers CEOGalway-based ONK Therapeutics Ltd....
Items per page:
1 - 3 of 3
BioCentury | Jan 23, 2021
Emerging Company Profile

ONK’s CAR NK cells hit the TRAIL

...2015, has applied its dual targeting allogeneic NK cell platform to four preclinical programs.Last year, ONK Therapeutics Ltd....
...1 SIGLEC7- Sialic acid binding Ig like lectin 7TRAIL - Tumor necrosis factor -related apoptosis-inducing ligand Karen Tkach Tuzman ONK Therapeutics Ltd. Glycotope...
BioCentury | Jan 16, 2021
Management Tracks

FDA’s Schiller joins Aetion; plus Novavax, NHC, NextCure, Ziopharm, ONK

...biotechs, including GenScript Biotech Corp. (HKEX:1548), Legend Biotech Corp. (NASDAQ:LEGN) and Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688).ONK Therapeutics Ltd. appointed...
...succeeds founder Anthony Killarney, who remains on the board of the Irish cell therapy company. BC Staff Novavax Aetion FDA Ziopharm ONK Therapeutics Ltd. NextCure...
BioCentury | Oct 20, 2020
Deals

Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta

...the treatment to patients for decades at no charge.ONK raises $8M, appoints Chris Nowers CEOGalway-based ONK Therapeutics Ltd....
Items per page:
1 - 3 of 3